Pletal
Drug - Pletal
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Cilostazol
Multiple ingredients are in alphabetical order.
Strength -
50MG
The potency of the active ingredient(s), Cilostazol. May repeat for multiple part products.
Applicant -
OTSUKA
The firm name holding legal responsibility for Pletal. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
020863
The FDA assigned number to Pletal. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Pletal. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Jan 15, 1999
The date Pletal was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Pletal. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Pletal is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Otsuka Pharmaceutical Co Ltd
The full name of the firm holding legal responsibility for the new application of Pletal.
Pletal
|
